“Comparing The Safety And Efficacy Of Sitagliptin Vs Dapagliflozin And The Risk Of Hyperkalaemia Among People With Type 2 Diabetes Mellitus And Kidney Disease ”. Vascular and Endovascular Review 8, no. 9s (November 14, 2025): 230–236. Accessed June 8, 2026. https://verjournal.com/index.php/ver/article/view/745.